Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study

BACKGROUND: Recent large clinical trials have demonstrated cardiovascular benefits of similar overall magnitude for sodium–glucose cotransporter-2 inhibitor (SGLT-2i) and glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy in subjects with type 2 diabetes. We sought to identify subgroups base...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohn, Minji, Dietrich, Johannes W., Nauck, Michael A., Lim, Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303335/
https://www.ncbi.nlm.nih.gov/pubmed/37381019
http://dx.doi.org/10.1186/s12933-023-01877-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303335/
https://www.ncbi.nlm.nih.gov/pubmed/37381019
http://dx.doi.org/10.1186/s12933-023-01877-6

Ejemplares similares